Potent antitumor immunity generated by a CD40-targeted adenoviral vaccine.
Hangalapura BN, Oosterhoff D, de Groot J, Boon L, Tüting T, van den Eertwegh AJ, Gerritsen WR, van Beusechem VW, Pereboev A, Curiel DT, Scheper RJ, de Gruijl TD.
Hangalapura BN, et al. Among authors: de groot j, de gruijl td.
Cancer Res. 2011 Sep 1;71(17):5827-37. doi: 10.1158/0008-5472.CAN-11-0804. Epub 2011 Jul 11.
Cancer Res. 2011.
PMID: 21747119
Free article.